Otto Balsiger
@obalsiger.bsky.social
Director of Finance, Membership and Publishing at the British Society for Immunology (BSI), also Treasurer/Trustee of Applied Microbiology International (AMI). Dad who loves science and sports (especially #immunology and #taekwondo) All views are my own.
Reposted by Otto Balsiger
Data from our UK-wide workforce report shows huge variation in immunology consultant numbers, leaving many services extremely fragile.
Scotland faces the most severe shortage, with only 2.7 full-time equivalent consultants in the country, serving over 2 million people each.
Scotland faces the most severe shortage, with only 2.7 full-time equivalent consultants in the country, serving over 2 million people each.
January 30, 2026 at 4:29 PM
Data from our UK-wide workforce report shows huge variation in immunology consultant numbers, leaving many services extremely fragile.
Scotland faces the most severe shortage, with only 2.7 full-time equivalent consultants in the country, serving over 2 million people each.
Scotland faces the most severe shortage, with only 2.7 full-time equivalent consultants in the country, serving over 2 million people each.
Reposted by Otto Balsiger
🚀 New in Immunotherapy Advances! Margherita Boieri et al. from Zelluna ASA report promising preclinical data on MAGE‑A4–specific TCR‑NK cells, showing potent, safe activity against solid tumors.
Read the open access article: https://bit.ly/3Z8hDBW
##Immunotherapy #CellTherapy
Read the open access article: https://bit.ly/3Z8hDBW
##Immunotherapy #CellTherapy
January 30, 2026 at 4:39 PM
🚀 New in Immunotherapy Advances! Margherita Boieri et al. from Zelluna ASA report promising preclinical data on MAGE‑A4–specific TCR‑NK cells, showing potent, safe activity against solid tumors.
Read the open access article: https://bit.ly/3Z8hDBW
##Immunotherapy #CellTherapy
Read the open access article: https://bit.ly/3Z8hDBW
##Immunotherapy #CellTherapy
Reposted by Otto Balsiger
🔬 Discovery Immunology features a review by Sara Alonso & Karen L. Edelblum exploring how intestinal microenvironments and the gut microbiota shape the metabolism and function of γδ intraepithelial lymphocytes.
Read the open access article: https://bit.ly/4a6rY6a
Read the open access article: https://bit.ly/4a6rY6a
January 30, 2026 at 4:53 PM
🔬 Discovery Immunology features a review by Sara Alonso & Karen L. Edelblum exploring how intestinal microenvironments and the gut microbiota shape the metabolism and function of γδ intraepithelial lymphocytes.
Read the open access article: https://bit.ly/4a6rY6a
Read the open access article: https://bit.ly/4a6rY6a
Reposted by Otto Balsiger
🔬 Jan Devan et al. identify distinct pro‑inflammatory T‑cell populations in Crohn’s disease lesions, including CD4⁺CD39⁺ TCRαβ⁺ cells and activated TCR Vδ1⁺ cells, highlighting potential new therapeutic targets.
Read the article: https://bit.ly/3LitpGu
#CrohnsDisease
Read the article: https://bit.ly/3LitpGu
#CrohnsDisease
January 30, 2026 at 5:29 PM
🔬 Jan Devan et al. identify distinct pro‑inflammatory T‑cell populations in Crohn’s disease lesions, including CD4⁺CD39⁺ TCRαβ⁺ cells and activated TCR Vδ1⁺ cells, highlighting potential new therapeutic targets.
Read the article: https://bit.ly/3LitpGu
#CrohnsDisease
Read the article: https://bit.ly/3LitpGu
#CrohnsDisease
Reposted by Otto Balsiger
We are pleased to launch the new BSI-CIPN Clinical Audit Grants! Up to £5,000 is available to support UK based clinical audit activity in clinical immunology, funded by an educational grant from Grifols.
Deadline: 23 Feb 2026.
Find out more and apply: https://bit.ly/49ULl3k
Deadline: 23 Feb 2026.
Find out more and apply: https://bit.ly/49ULl3k
January 29, 2026 at 11:46 AM
We are pleased to launch the new BSI-CIPN Clinical Audit Grants! Up to £5,000 is available to support UK based clinical audit activity in clinical immunology, funded by an educational grant from Grifols.
Deadline: 23 Feb 2026.
Find out more and apply: https://bit.ly/49ULl3k
Deadline: 23 Feb 2026.
Find out more and apply: https://bit.ly/49ULl3k
Will you join me at this meeting?
⌛Time is running out!
Abstract submission closes tomorrow. Don't miss your chance to present your work at #SIGNET26
Join the Scottish immunology community in Perth to network, share the latest findings and explore new breakthroughs
🔗 Find out more https://bit.ly/49VL6FA
Abstract submission closes tomorrow. Don't miss your chance to present your work at #SIGNET26
Join the Scottish immunology community in Perth to network, share the latest findings and explore new breakthroughs
🔗 Find out more https://bit.ly/49VL6FA
January 29, 2026 at 8:24 PM
Will you join me at this meeting?
Reposted by Otto Balsiger
📘 See CEI’s top-performing papers of 2025!
Explore our 2025 must‑read articles, highlighting impactful immunology research
Read more: https://bit.ly/45ELeXc
Explore our 2025 must‑read articles, highlighting impactful immunology research
Read more: https://bit.ly/45ELeXc
January 29, 2026 at 2:35 PM
📘 See CEI’s top-performing papers of 2025!
Explore our 2025 must‑read articles, highlighting impactful immunology research
Read more: https://bit.ly/45ELeXc
Explore our 2025 must‑read articles, highlighting impactful immunology research
Read more: https://bit.ly/45ELeXc
Reposted by Otto Balsiger
🔍 See the research that made the biggest impact this year!
Check out our 2025 must‑read articles, featuring the most-read and most‑cited work
Read more: https://bit.ly/45ELeXc
##Immunology
Check out our 2025 must‑read articles, featuring the most-read and most‑cited work
Read more: https://bit.ly/45ELeXc
##Immunology
January 29, 2026 at 2:31 PM
🔍 See the research that made the biggest impact this year!
Check out our 2025 must‑read articles, featuring the most-read and most‑cited work
Read more: https://bit.ly/45ELeXc
##Immunology
Check out our 2025 must‑read articles, featuring the most-read and most‑cited work
Read more: https://bit.ly/45ELeXc
##Immunology
These are some great articles - if you haven't already check them out
✨ Our 2025 must‑read articles are now live!
Explore the most‑viewed and most‑cited immunotherapy papers from the past year
Discover them here: https://bit.ly/45ELeXc
##Immunotherapy
Explore the most‑viewed and most‑cited immunotherapy papers from the past year
Discover them here: https://bit.ly/45ELeXc
##Immunotherapy
January 29, 2026 at 7:57 PM
These are some great articles - if you haven't already check them out
Reposted by Otto Balsiger
🚨 Deadline approaching! Last chance to present your work at #SIGNET26.
Abstract submissions close this Thursday, 29 January, with oral presentation slots reserved for postdocs and PhD students, plus poster prizes.
🔗 https://bit.ly/49VL6FA
Abstract submissions close this Thursday, 29 January, with oral presentation slots reserved for postdocs and PhD students, plus poster prizes.
🔗 https://bit.ly/49VL6FA
January 27, 2026 at 10:20 AM
🚨 Deadline approaching! Last chance to present your work at #SIGNET26.
Abstract submissions close this Thursday, 29 January, with oral presentation slots reserved for postdocs and PhD students, plus poster prizes.
🔗 https://bit.ly/49VL6FA
Abstract submissions close this Thursday, 29 January, with oral presentation slots reserved for postdocs and PhD students, plus poster prizes.
🔗 https://bit.ly/49VL6FA
Reposted by Otto Balsiger
Just one week left to apply for the BSI Communication & Engagement Grant!
Share your passion, improve public understanding & build trust in science through creative engagement projects.
Up to £1,000 available. Submit by 1 February to inspire & educate: https://bit.ly/3Y9j8gm
Share your passion, improve public understanding & build trust in science through creative engagement projects.
Up to £1,000 available. Submit by 1 February to inspire & educate: https://bit.ly/3Y9j8gm
January 26, 2026 at 9:55 AM
Just one week left to apply for the BSI Communication & Engagement Grant!
Share your passion, improve public understanding & build trust in science through creative engagement projects.
Up to £1,000 available. Submit by 1 February to inspire & educate: https://bit.ly/3Y9j8gm
Share your passion, improve public understanding & build trust in science through creative engagement projects.
Up to £1,000 available. Submit by 1 February to inspire & educate: https://bit.ly/3Y9j8gm
Reposted by Otto Balsiger
More myths about vaccines debunked
CIDRAP Op-ed: Vaccine myths that won’t die and how to counter them—part 2
www.cidrap.umn.edu
January 26, 2026 at 10:33 AM
More myths about vaccines debunked
Reposted by Otto Balsiger
Join sector leaders from industry, academia & the clinic at the BSI Immune Therapies Summit 🧬
📅 18–19 May 2026 | 📍 Cambridge, UK
Two days of cutting-edge science, networking & discussion shaping the future of immune therapies.
Learn more: https://bit.ly/3LW5uNc
📅 18–19 May 2026 | 📍 Cambridge, UK
Two days of cutting-edge science, networking & discussion shaping the future of immune therapies.
Learn more: https://bit.ly/3LW5uNc
January 20, 2026 at 3:50 PM
Join sector leaders from industry, academia & the clinic at the BSI Immune Therapies Summit 🧬
📅 18–19 May 2026 | 📍 Cambridge, UK
Two days of cutting-edge science, networking & discussion shaping the future of immune therapies.
Learn more: https://bit.ly/3LW5uNc
📅 18–19 May 2026 | 📍 Cambridge, UK
Two days of cutting-edge science, networking & discussion shaping the future of immune therapies.
Learn more: https://bit.ly/3LW5uNc
Reposted by Otto Balsiger
Registration is now open for the Oxford Immunology Symposium 2026! #OIS26
Join us on Wed 1 April at the Mathematical Institute, University of Oxford, for a one day showcase of immunology research across Oxford.
Register now & submit an abstract here: https://bit.ly/4qUY8bD
Join us on Wed 1 April at the Mathematical Institute, University of Oxford, for a one day showcase of immunology research across Oxford.
Register now & submit an abstract here: https://bit.ly/4qUY8bD
January 19, 2026 at 10:20 AM
Registration is now open for the Oxford Immunology Symposium 2026! #OIS26
Join us on Wed 1 April at the Mathematical Institute, University of Oxford, for a one day showcase of immunology research across Oxford.
Register now & submit an abstract here: https://bit.ly/4qUY8bD
Join us on Wed 1 April at the Mathematical Institute, University of Oxford, for a one day showcase of immunology research across Oxford.
Register now & submit an abstract here: https://bit.ly/4qUY8bD
Reposted by Otto Balsiger
Really looking forward to speaking (for the 3rd year!) at the British Society for Immunology (@britsocimm.bsky.social) Foundations of Immunology course on 18 March 🧬
A brilliant one-day online course covering core immunology for all backgrounds 🧪
Register 👉 www.immunology.org/training/Fou...
A brilliant one-day online course covering core immunology for all backgrounds 🧪
Register 👉 www.immunology.org/training/Fou...
January 14, 2026 at 11:08 AM
Really looking forward to speaking (for the 3rd year!) at the British Society for Immunology (@britsocimm.bsky.social) Foundations of Immunology course on 18 March 🧬
A brilliant one-day online course covering core immunology for all backgrounds 🧪
Register 👉 www.immunology.org/training/Fou...
A brilliant one-day online course covering core immunology for all backgrounds 🧪
Register 👉 www.immunology.org/training/Fou...
If you get the chance do come to this meeting if promises to he a great one..
Immunometabolism researchers are meeting in Newcastle on 16-17 April!
Join us for 2 days of fantastic immunometabolism research, Bright Sparks sessions & networking with the community. #UKimmunomet26
Submit your abstract by 5 March and register now 👉 https://bit.ly/493uE45
Join us for 2 days of fantastic immunometabolism research, Bright Sparks sessions & networking with the community. #UKimmunomet26
Submit your abstract by 5 March and register now 👉 https://bit.ly/493uE45
January 15, 2026 at 5:19 PM
If you get the chance do come to this meeting if promises to he a great one..
Reposted by Otto Balsiger
Low MHC‑I expression remains a major barrier to effective tumour immunotherapy, especially in paediatric cancers.
This review outlines mechanisms of MHC‑I downregulation and emerging approaches to restore antigen presentation.
📄 https://bit.ly/45vtfmp
This review outlines mechanisms of MHC‑I downregulation and emerging approaches to restore antigen presentation.
📄 https://bit.ly/45vtfmp
January 15, 2026 at 11:30 AM
Low MHC‑I expression remains a major barrier to effective tumour immunotherapy, especially in paediatric cancers.
This review outlines mechanisms of MHC‑I downregulation and emerging approaches to restore antigen presentation.
📄 https://bit.ly/45vtfmp
This review outlines mechanisms of MHC‑I downregulation and emerging approaches to restore antigen presentation.
📄 https://bit.ly/45vtfmp
Reposted by Otto Balsiger
Type‑17 immunity shows up in the gut: axSpA stool contains increased IL‑17A, IL‑23 & GM‑CSF, alongside systemic Th17 activation.
Metabolomics points to microbial metabolic links.
Read here: https://bit.ly/4nkhC7q
Metabolomics points to microbial metabolic links.
Read here: https://bit.ly/4nkhC7q
January 13, 2026 at 11:55 AM
Type‑17 immunity shows up in the gut: axSpA stool contains increased IL‑17A, IL‑23 & GM‑CSF, alongside systemic Th17 activation.
Metabolomics points to microbial metabolic links.
Read here: https://bit.ly/4nkhC7q
Metabolomics points to microbial metabolic links.
Read here: https://bit.ly/4nkhC7q
Reposted by Otto Balsiger
MOG/NMDAR overlapping syndrome is increasingly recognised.
This review shows common symptoms (psychiatric changes, seizures), typical MRI patterns, good treatment response, but a notably higher recurrence rate.
Read here📄 https://bit.ly/3Q2S29A
This review shows common symptoms (psychiatric changes, seizures), typical MRI patterns, good treatment response, but a notably higher recurrence rate.
Read here📄 https://bit.ly/3Q2S29A
January 15, 2026 at 2:46 PM
MOG/NMDAR overlapping syndrome is increasingly recognised.
This review shows common symptoms (psychiatric changes, seizures), typical MRI patterns, good treatment response, but a notably higher recurrence rate.
Read here📄 https://bit.ly/3Q2S29A
This review shows common symptoms (psychiatric changes, seizures), typical MRI patterns, good treatment response, but a notably higher recurrence rate.
Read here📄 https://bit.ly/3Q2S29A
Can’t wait for this one..
Who's excited for #SIGNET26?
Join immunologists from across Scotland on Wednesday 11 March 2026 for a full day, in person symposium with keynote talks, ECR presentations, posters and networking.
Submit your abstract by 29 January and register now 👉 https://bit.ly/49VL6FA
Join immunologists from across Scotland on Wednesday 11 March 2026 for a full day, in person symposium with keynote talks, ECR presentations, posters and networking.
Submit your abstract by 29 January and register now 👉 https://bit.ly/49VL6FA
January 15, 2026 at 12:01 AM
Can’t wait for this one..
Reposted by Otto Balsiger
Want to take your omic data analysis to the next level?
Our advanced R course for wet lab immunologists starts on 2 February 2026, with five online Monday sessions covering statistics, clinical data, RNA seq and proteomics.
Register now 👉 https://bit.ly/47kXFaC
Our advanced R course for wet lab immunologists starts on 2 February 2026, with five online Monday sessions covering statistics, clinical data, RNA seq and proteomics.
Register now 👉 https://bit.ly/47kXFaC
January 12, 2026 at 10:45 AM
Want to take your omic data analysis to the next level?
Our advanced R course for wet lab immunologists starts on 2 February 2026, with five online Monday sessions covering statistics, clinical data, RNA seq and proteomics.
Register now 👉 https://bit.ly/47kXFaC
Our advanced R course for wet lab immunologists starts on 2 February 2026, with five online Monday sessions covering statistics, clinical data, RNA seq and proteomics.
Register now 👉 https://bit.ly/47kXFaC
Reposted by Otto Balsiger
Despite elevated KLR and mitochondrial gene expression, Tregs in autoimmune PAI show normal frequency and suppressive function, suggesting limited involvement in disease pathogenesis.
📄 https://bit.ly/3Q2QVGU
📄 https://bit.ly/3Q2QVGU
January 12, 2026 at 11:00 AM
Despite elevated KLR and mitochondrial gene expression, Tregs in autoimmune PAI show normal frequency and suppressive function, suggesting limited involvement in disease pathogenesis.
📄 https://bit.ly/3Q2QVGU
📄 https://bit.ly/3Q2QVGU
Reposted by Otto Balsiger
How do human ILCs adapt to lung niches?
Single‑cell profiling shows distinct vascular vs. tissue programs and a shared extravascular “tissue signature” with NK cells.
Read here: https://bit.ly/4qiLJP6
Single‑cell profiling shows distinct vascular vs. tissue programs and a shared extravascular “tissue signature” with NK cells.
Read here: https://bit.ly/4qiLJP6
January 9, 2026 at 1:45 PM
How do human ILCs adapt to lung niches?
Single‑cell profiling shows distinct vascular vs. tissue programs and a shared extravascular “tissue signature” with NK cells.
Read here: https://bit.ly/4qiLJP6
Single‑cell profiling shows distinct vascular vs. tissue programs and a shared extravascular “tissue signature” with NK cells.
Read here: https://bit.ly/4qiLJP6
Reposted by Otto Balsiger
Submissions now open for the Extracellular Vesicles & Immune Function topic—exosomes, microvesicles, immunomodulation, disease mechanisms & therapy.
Submit by May 2026: https://bit.ly/3YpmLRI
Submit by May 2026: https://bit.ly/3YpmLRI
January 8, 2026 at 10:34 AM
Submissions now open for the Extracellular Vesicles & Immune Function topic—exosomes, microvesicles, immunomodulation, disease mechanisms & therapy.
Submit by May 2026: https://bit.ly/3YpmLRI
Submit by May 2026: https://bit.ly/3YpmLRI
Reposted by Otto Balsiger
High‑throughput long‑read sequencing uncovers how chickens diversify their Ig genes: dominant somatic gene conversion, biased pseudogene usage, and focused CDR‑targeted insertions.
A look into avian antibody evolution: https://bit.ly/45wSe95
A look into avian antibody evolution: https://bit.ly/45wSe95
January 7, 2026 at 2:58 PM
High‑throughput long‑read sequencing uncovers how chickens diversify their Ig genes: dominant somatic gene conversion, biased pseudogene usage, and focused CDR‑targeted insertions.
A look into avian antibody evolution: https://bit.ly/45wSe95
A look into avian antibody evolution: https://bit.ly/45wSe95